COLUMBUS, Ohio – Dr. Michael Caligiuri (43220), director of The Ohio State University Comprehensive Cancer Center, has been elected to a three-year term on the board of directors of the Association of American Cancer Institutes (AACI).
Michael A. Caligiuri, M.D.
The AACI comprises National Cancer Institute-designated cancer centers and academic-based cancer research programs that receive NCI support. It provides cancer center leaders a forum where they can share ideas about research, policy, education and professional training, among other issues.
Caligiuri holds the John L. Marakas Nationwide Insurance Enterprise Foundation Chair in Cancer Research at Ohio State and is also a professor in the department of internal medicine and a Cancer Genetics Scholar in the department of molecular virology, immunology and medical genetics. His research focuses on various aspects of leukemia and lymphoma and how the innate immune system affects cancer growth and development.
He is the author of more than 130 peer-reviewed scientific publications and is a member of the editorial boards of some of the world’s most prestigious medical journals. He also holds numerous leadership positions in professional organizations and clinical societies throughout the country.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is one of the nation’s leading centers for research on the prevention, detection, diagnosis and treatment of cancer. The OSUCCC-James encompasses six interdisciplinary research programs and includes more than 200 investigators who generate over $100 million annually in external funding. OSU James, a founding member of the National Comprehensive Cancer Network, is ranked by U.S. News & World Report as one of America’s best cancer hospitals.# # #
Medical Center Communications